The feasibility of finger prick autologous blood (FAB) as a novel treatment for severe dry eye disease (DED): protocol for a randomised controlled trial

INTRODUCTION: Patients with severe dry eye disease (DED) often have limited treatment options with standard non-surgical management focused on the use of artificial tears for lubrication and anti-inflammatory drugs. However, artificial tears do not address the extraordinary complexity of human tears...

Descripción completa

Detalles Bibliográficos
Autores principales: Balal, Shafi, Udoh, Arit, Pappas, Yannis, Cook, Erica, Barton, Garry, Hassan, Ali, Hayden, Karen, Bourne, Rupert Richard Alexander, Ahmad, Sajjad, Pardhan, Shahina, Harrison, Michael, Sharma, Benjamin, Wasil, Mohammad, Sharma, Anant
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Ophthalmology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252631/
https://www.ncbi.nlm.nih.gov/pubmed/30385451
http://dx.doi.org/10.1136/bmjopen-2018-026770

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252631/
https://www.ncbi.nlm.nih.gov/pubmed/30385451
http://dx.doi.org/10.1136/bmjopen-2018-026770

Ejemplares similares